Kewaunee Scientific (KEQU) Financials

$33.91

$-0.54 (-1.57%)

As on 01-Oct-2026 16:00EDT

Market cap

$99 Mln

Revenue (TTM)

$277 Mln

P/E Ratio

12.2

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Operating Revenue	277.22	282.00	240.47	203.76	219.49	168.87
Cost of Revenue	198.07	201.56	171.62	151.70	183.91	144.65
Gross Profit	79.15	80.44	68.86	52.05	35.59	24.22
Operating Expenses	64.09	63.73	51.10	33.77	30.22	26.83
Operating Profit (EBIT)	15.06	16.72	17.76	18.28	3.63	-2.61
Other Income	--	--	--	--	--	--
Profit before Tax	12.37	13.73	14.79	13.12	4.50	-2.49
Provision for Tax	3.22	3.27	3.20	-5.94	3.14	3.52
Profit after Tax (Net Income)	8.23	9.62	11.41	18.75	1.36	-6.00
Minority Interest	-0.92	-0.85	-0.18	-0.30	-0.62	-0.12
Consolidated Profit	--	--	--	--	0.74	-6.13

Liabilities ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Shareholder's Funds	75.01	74.72	64.46	54.76	37.41	35.69
Minority Interest	-0.92	--	--	--	--	--
Non-Current Liabilities	51.35	53.15	74.70	37.78	40.36	40.30
Current Liabilities	47.24	48.35	53.71	40.78	40.05	42.29
Total Liabilities	223.04	178.31	194.65	134.77	118.90	118.77

Assets ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Non-Current Assets	71.85	72.91	76.29	37.95	30.98	27.21
Current Assets	103.95	105.40	118.36	96.82	87.92	91.57
Total Assets	223.04	178.31	194.65	134.77	118.90	118.77
Total Debt*	55.47	30.19	50.16	11.00	12.92	67.57
Net Current Assets	56.72	57.05	64.65	56.04	47.87	49.27

Cashflow ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Cash From Operating Activities	--	18.63	14.78	19.56	-3.79	-7.89
Cash Flow from Investing Activities	--	-3.94	-30.90	-4.37	-4.15	-1.91
Cash from Financing Activities	--	-19.33	7.41	-3.01	14.93	11.03
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
ROCE (%)	--	8.76	12.65	32.31	1.77	-7.47
ROE (%)	10.04	13.82	19.13	40.69	3.72	-15.61
ROA (%)	3.53	5.16	6.92	14.79	1.14	-5.77
EBIT Margin (%)	5.69	6.24	7.48	7.32	2.41	-1.10
Net Margin (%)	2.97	3.41	4.74	9.20	0.62	-3.55
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Revenue Growth (%)	5.33	0.17	0.18	-0.07	0.30	0.15
EBIT Growth (%)	-21.42	-2.24	20.65	181.84	385.64	16.83
Net Profit Growth (%)	-39.59	-15.67	-39.18	1,279.91	122.64	-66.43
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Price / Earnings	12.24	--	--	--	--	--
Price / Book Value	1.34	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	5.48	0.78	1.55	-0.68	0.59	68.92
Close Price ($)	35.72	37.01	31.67	35.70	16.25	14.26
High Price ($)	60.89	60.89	71.33	36.90	20.48	14.99
Low Price ($)	33.27	30.78	30.33	14.56	13.55	11.44
Market Cap ($ Cr)	98.50	--	--	--	--	--

Solvency Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Debt to Equity	0.18	0.40	0.78	0.20	0.35	1.89
Short term debt to equity ratio	0.14	0.12	0.11	0.10	0.15	0.10
Current Ratio	2.20	2.18	2.20	2.37	2.20	2.17
Quick Ratio	1.57	1.55	1.59	1.87	1.65	1.60
Interest Coverage	4.61	4.56	5.60	8.29	3.05	-2.93

Operating Efficiency Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Debtors to sales (%)	20.99	20.83	25.94	22.12	20.99	32.40
Asset Turnover	1.19	1.51	1.46	1.61	1.85	1.62
Receivable days	--	78.44	81.60	81.69	83.86	94.73
Inventory Days	--	57.43	56.96	51.24	45.37	50.90
Payable days	--	44.84	53.52	56.41	50.56	55.67
Cash Conversion Cycle	--	91.03	85.04	76.52	78.67	89.95

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.